期刊文献+

化学物的神经毒性体外评价方法 被引量:2

Methods for in vitro assessment of neurotoxicants
暂未订购
导出
摘要 神经系统毒性反应是药物常见的毒性反应。神经系统对外源性和内源性毒性物质的攻击都十分敏感,因而毒性作用的结果也可能较其他系统更为严重。神经毒性的体外评价主要用于药物筛选的早期阶段以及毒性机制研究。神经毒性的体外评价以各种培养的细胞和组织模型为基础,随着体外培养的复杂程度增加,培养物与活体内组织的相似性越高。体外评价的终点包括一般细胞毒性指标、神经轴突生长的形态学指标和反映特异神经毒性的指标。 Neurotoxicity is the most common adverse drug reaction seen in clinic. The nervous system is more sensitive to internal and external toxic attacks. Therefore, neurotoxicants may exert more serious effects than general toxic chemicals. At present, in vitro neurotoxicity assessment is mainly applied in early pharmaceutical screening and toxic mechanism study. Neurotoxic tests are performed on the basis of different kinds of cell and tissue culture systems. As the complexity of the culture systems increases, cells in these systems gain more features resembling those in vivo.Endpoints used in these tests usually involve general cytotoxicity, morphological changes associated with neurite outgrowth and parameters of specific neurotoxicity.
作者 徐蓓 杜冠华
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2008年第4期311-315,共5页 Chinese Journal of Pharmacology and Toxicology
基金 国家自然科学基金重点项目(30630073)~~
关键词 神经系统/毒性 细胞培养技术 神经元 神经化学 nervous system/toxicity cell culture techniques neurons neurochemistry
  • 相关文献

参考文献40

  • 1Olson H, Betton G, Robinson D, Thomas K, Monro A, Kolaja G, et al. Concordance of the toxicity of pharmaceuticals in humans and in animals[J]. Regul Toxicol Pharmacol, 2000, 32 ( 1 ) :56 -67.
  • 2Costa LG. Neurotoxicity testing: a discussion of in vitro alternatives [J]. Environ Health Perspect, 1998, 106(Suppl 2) :505 -510.
  • 3Abdulla EM, Campbell IC. In vitro tests of neurotoxicity[ J]. J Pharmacol Toxicol Methods, 1993, 29 ( 2 ) :69 - 75.
  • 4Sakai Y, Shoji R, Mishima Y, Sakoda A, Suzuki M. Rapid and sensitive neurotoxicity test based on the morphological changes of PC12 cells with simple computer-assisted image analysis [ J ]. J Biosci Bioeng, 2000, 90( 1 ) :20 -24.
  • 5Westerink RH, Vijverberg HP. Vesicular catecholamine release from rat PG12 cells on acute and subchronic exposure to polychlorinated biphenyls[ J ]. Toxicol Appl Pharmacol, 2002, 183 ( 3 ) : 153 - 159.
  • 6Blanchard BJ, Chen A, Rozeboom LM, Stafford KA, Weigele P, Ingrain VM. Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxlcity by a small molecule [J]. Proc Natl Acad Sci USA, 2004, 101 (40) : 14326 - 14332.
  • 7Kang JH, Jeong W, Park Y, Lee SY, Chung MW, Lim HK, et al. Aroclor 1254-induced cytotoxicity in catecholaminergic CATH. A cells related to the inhibition of NO production [ J ]. Toxicology, 2002, 177 ( 2 - 3 ) : 157 - 166.
  • 8Lee DW, Opanashuk LA. Polychlorinated biphenyl mixture Areclot 1254-induced oxidative stress plays a role in dopaminergic cell injury[J]. Neurotoxicology, 2004, 25(6) :925 -939.
  • 9Presgraves SP, Borwege S, Millan M J, Joyce JN. Involvement of dopamine D2/D3 receptors and BDNF in the neuropmtective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells [ J ]. Exp Neurol, 2004, 190( 1 ) : 157 - 170.
  • 10Mead C, Pentreath VW. Evaluation of toxicity indicators in rat primary astrocytes, C6 glioma and human 1321N1 astrocytoma cells: can gliotoxicity be distinguished from cytotoxicity[J] ? Arch Toxicol, 1998, 72(6 ) :372 - 380.

同被引文献43

  • 1Schoonen WG, Westerink WM, Horbach GJ. High-throughput screening for analysis of in vitro toxicity [J]. EXS, 2009, 99 : 401-452.
  • 2Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? [J]. Nat Rev Drug Discov, 2004, 3(8) :711-715.
  • 3Dragunow M. High-content analysis in neumscience[ J]. Nat Rev Neurosci, 2008, 9(10):779-788.
  • 4Xu JJ, Diaz D, O'Brien PJ. Applications of cytotoxicity assays and pre-lethal mechanistic assays for assessment of human hepatotoxicity potential[J]. Chem Biol Interact, 2004, 150( 1 ) :115-128.
  • 5Rausch O. High content cellular screening[J]. Curr Opin Chem Biol, 2006, 10(4) :316-320.
  • 6O'Brien PJ, Irwin W, Diaz D, Howard-Cofield E, Krejsa CM, Slaughter MR, et al. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell- based model using high content screening [ J ]. Arch Toxicol, 2006, 80(9) :580-604.
  • 7O'Brien P, Haskins JR. In vitro cytotoxicity assessment[ M] ff Taylor DL, Haskins JR, Giuliano KA. High Content Screening: A Powerful Approach to Systems Cell Biology and Drug Discovery. Totova: Humana Press, 2007:424.
  • 8Kim JA, Han E, Eun CJ, Tak YK, Song JM. Real-time concur- rent monitoring of apoptosis, cytosolic calcium, and mitochondfia permeability transition for hypermulticolor high-content screening of drug-induced mitochondrial dysfunction-mediated hepatotoxicity [J]. Toxicol Left, 2012, 214(2) :175-181.
  • 9Tolosa L, Pinto S, Donato Mr, Ioz A, Castell JV, O'Connor JE, et al. Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs [ J ]. Toxicol Sci, 2012, 127(1) :187-198.
  • 10Peng SQ, Hao WD, Wu YJ. Toxicology Alternative Method [M]. Beijing: Military Medical Science Press, 2008:396-430.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部